IMCR

Immunocore Holdings Plc

• Reuters·2d ago

  Immunocore to present at Needham Virtual Healthcare Conference fireside chat

• TipRanks·6d ago

  Analysts’ Top Healthcare Picks: Nurix Therapeutics (NRIX), Immunocore Holdings (IMCR)

• Benzinga·03/31 14:51

  FDA Adverse Event Monitoring System Q4 2025 Flags Multiple Potential New Drug Safety Signals, Including Hypersensitivity, Hypogammaglobulinemia, Colitis, Aplastic Anemia And Rhabdomyolysis Under Evaluation

• Simply Wall St·03/26 13:09

  Assessing Immunocore Holdings (IMCR) Valuation After Analyst Downgrade And Pipeline Timing Shift

• Benzinga·03/17 20:33

  Immunocore Holdings To Present 5-Yr OS From KIMMTRAK Phase 3 Trial In Previously Untreated HLA-A*02:01 Positive Patients With Unresected Or mUM, At 2026 AACR Annual Meeting

• Reuters·03/17 20:31

  Immunocore to present five-year overall survival data for KIMMTRAK at AACR meeting

• TipRanks·03/16 13:40

  Qualcomm, Adobe downgraded: Wall Street’s top analyst calls

• Dow Jones·03/16 13:03

  Immunocore Holdings Price Target Cut to $33.00/Share From $48.00 by Jefferies

• Dow Jones·03/16 13:03

  Immunocore Holdings Cut to Hold From Buy by Jefferies

• Benzinga·03/16 12:53

  Jefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33

• TipRanks·03/16 09:20

  Immunocore downgraded to Hold from Buy at Jefferies

• Simply Wall St·03/10 13:19

  Will Immunocore's (IMCR) 2025 Revenue Growth and Narrower Loss Reshape Its Investment Narrative?

• Simply Wall St·03/06 09:34

  Assessing Immunocore (IMCR) Valuation After Earnings Show Revenue Growth And Narrower Full Year Loss

• TipRanks·03/04 11:25

  Immunocore: Strong KIMMTRAK Execution, Robust Late-Stage Pipeline, and Cash-Funded Catalysts Support Buy Rating and $100 Target

• Reuters·03/03 12:02

  Immunocore to present at upcoming investor conferences